This proposal describes the career development program of David L. Sultzer, M.D., and requests two additional years of support by the Clinical Mental Health Academic Award in Geriatric Psychiatry. Dr. Sultzer received the three-year Academic Award in 1991. Accomplishments during the initial three years of the program at UCLA include: 1. Research productivity. The severity of specific psychiatric symptoms in 61 patients with Alzheimer's disease (AD) has been examined. A comparison of psychiatric symptoms in patients with AD and those with vascular dementia has shown that depression, anxiety, and behavioral retardation are more severe in patients with vascular dementia. A positron emission tomography (PET) study has shown that cortical hypometabolism is associated with both cognitive and noncognitive psychiatric symptoms in patients with AD. Preliminary evidence suggests that hypometabolism in the frontal cortex contributes prominently to agitation and psychotic symptoms. Results from these studies have been presented at national meetings and are currently published, in press, or in submission. 2. Academic development. Dr. Sultzer has gained basic skills in PET imaging techniques, has completed coursework in biostatistics and research design, and has advanced his teaching skills. He is regarded as a promising academic leader in geriatric mental health. The proposed two-year program builds on the research progress and the academic skills that were developed during the initial Award period. Specific goals are: 1) to examine the mental health consequences of frontal lobe dysfunction in patients with AD, and 2) to gain advanced research skills in PET imaging and data analysis. The following activities are proposed to achieve these goals. 1. Dr. Sultzer will implement the research project: Frontal Lobe Dysfunction in Alzheimer's Disease. This study examines the longitudinal course of frontal hypometabolism in AD and tests the hypothesis that the progression of specific psychiatric symptoms in AD is associated with metabolic reduction in the frontal cortex. The study also examines the impact of frontal hypometabolism on the risk for nursing home placement and neuroleptic medication use. 2. Dr. Sultzer will complete additional focused training in PET methodology and neuroimage analysis, will supervise fellowship trainees at UCLA in their research projects, and will become a faculty expert in the phenomenology , pathophysiology, and treatment of psychiatric symptoms in AD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Academic/Teacher Award (ATA) (K07)
Project #
2K07MH000910-04
Application #
2240128
Study Section
Mental Disorders of Aging Review Committee (MDA)
Project Start
1991-07-01
Project End
1996-06-30
Budget Start
1994-09-01
Budget End
1995-06-30
Support Year
4
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Psychiatry
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Sultzer, David L; Chen, Stephen T; Brown, Charles V et al. (2002) Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings. J Neuropsychiatry Clin Neurosci 14:262-9
Harwood, Dylan G; Sultzer, David L (2002) ""Life is not worth living"": hopelessness in Alzheimer's disease. J Geriatr Psychiatry Neurol 15:38-43
Sultzer, D L; Gray, K F; Gunay, I et al. (2001) Does behavioral improvement with haloperidol or trazodone treatment depend on psychosis or mood symptoms in patients with dementia? J Am Geriatr Soc 49:1294-300
Harwood, D G; Sultzer, D L; Wheatley, M V (2000) Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances. Neuropsychiatry Neuropsychol Behav Neurol 13:83-8
Chen, S T; Sultzer, D L; Hinkin, C H et al. (1998) Executive dysfunction in Alzheimer's disease: association with neuropsychiatric symptoms and functional impairment. J Neuropsychiatry Clin Neurosci 10:426-32
Lavretsky, H; Sultzer, D (1998) A structured trial of risperidone for the treatment of agitation in dementia. Am J Geriatr Psychiatry 6:127-35
Sultzer, D L; Gray, K F; Gunay, I et al. (1997) A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia. Am J Geriatr Psychiatry 5:60-9
Sultzer, D L; Berisford, M A; Gunay, I (1995) The Neurobehavioral Rating Scale: reliability in patients with dementia. J Psychiatr Res 29:185-91
Sultzer, D L; Mahler, M E; Cummings, J L et al. (1995) Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings. Arch Neurol 52:773-80
Sultzer, D L; Mahler, M E; Mandelkern, M A et al. (1995) The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 7:476-84

Showing the most recent 10 out of 14 publications